ArticleBMC medicine2024

Immune checkpoint inhibitors in cancer: the increased risk of atherosclerotic cardiovascular disease events and progression of coronary artery calcium.

Bingxin Gong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.